On the subject of emerging weight loss drugs such as Ozempic and Mounjaro, Jitendra Singh advised caution, noting that while global experience may be encouraging, clinical outcomes often take decades to manifest. Drawing a parallel with the refined oils episode in India, he said hasty conclusions could be misleading.